Weekly Analysts’ Ratings Updates for Oaktree Specialty Lending (OCSL)

Several brokerages have updated their recommendations and price targets on shares of Oaktree Specialty Lending (NASDAQ: OCSL) in the last few weeks:

• 2/9/2026 – Oaktree Specialty Lending was downgraded by analysts at Weiss Ratings from a “hold (c-)” rating to a “sell (d+)” rating.
• 2/9/2026 – Oaktree Specialty Lending was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating.
• 2/7/2026 – Oaktree Specialty Lending was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating.
• 2/5/2026 – Oaktree Specialty Lending had its price target lowered by analysts at Wells Fargo & Company from $13.00 to $12.00. They now have an “equal weight” rating on the stock.
• 1/26/2026 – Oaktree Specialty Lending was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c-)” rating.
• 12/29/2025 – Oaktree Specialty Lending had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Oaktree Specialty Lending was downgraded by analysts at Weiss Ratings from a “hold (c-)” rating to a “sell (d+)” rating.

Oaktree Specialty Lending Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Monday, March 16th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, March 16th. This represents a $1.60 dividend on an annualized basis and a yield of 13.8%. Oaktree Specialty Lending’s payout ratio is presently 444.44%.

Oaktree Specialty Lending Corporation (NASDAQ: OCSL) is a closed-end, externally managed specialty finance company structured as a business development company (BDC). Launched in 2014, Oaktree Specialty Lending provides customized debt solutions to U.S. middle-market companies, with a focus on senior secured loans, second-lien financings, mezzanine debt and select equity co-investments. The company’s investment strategy centers on floating-rate instruments designed to offer downside protection and income potential in varying interest rate environments.

The firm’s portfolio spans a diverse array of industries, including healthcare, technology, energy, business services and consumer products.